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Abstract
Introduction: Cancer-related fatigue is one of the most common problems of patients with lung cancer. The assessment of cancer- 
-related fatigue is therefore a significant medical problem in patients during treatment with palliative chemotherapy.
Material and methods: The study included 100 patients during palliative chemotherapy because of lung cancer. The study was 
conducted in the Department of Pulmonary Diseases and Treatment of Lung Cancer in the Kuyavian and Pomeranian Centre of 
Pulmonology in Bydgoszcz, in the period from February to June 2016. The study used a socio-demographic questionnaire and 
Cancer Related Fatigue scale (CRF) consisting of 22 closed questions.
Results: Men accounted for 68% of the study group, people with vocational education — 61%, and people living in the city — 
61%. People aged 51–65 formed the largest group. The mean value for behavioural fatigue was 5.34 points, the sensory one — 
5.44 points, cognitive/mood fatigue — 4.29 points (moderate levels), whereas mean value for affective fatigue was at a serious 
level — 5.89 points. The average severity of general fatigue was 5.2 points (moderate level of fatigue). 
Conclusions: The moderate level of cancer-related fatigue occurs in half of patients treated with chemotherapy because of lung 
cancer, and lasts for several months. Behavioural, sensory, cognitive/mood and general fatigue have moderate levels but affective 
fatigue has a severe level. Radiation therapy affects the severity of cognitive/mood fatigue, lowers economic status, influences 
behavioural fatigue and education level, and has an effect on general fatigue. In multivariate analysis, only the reduction of eco-
nomic status has a significant impact on the severity of fatigue.
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Introduction
Lung cancer is the most common malignant 
tumour, it poses a huge epidemiological problem. 
Analysing the mortality rate, we note that it is 
the most common cause of cancer deaths in men 
and women. In Poland, the rate of incidence and 
mortality is higher than the respective average for 
the European Union countries [1, 2]. Lung cancer 
is in the advanced stage at the time of diagnosis in 
most patients and in many patients palliative care 
is needed [3]. The main goal of care is to reduce the 
burden of disease, improve quality of life, bring 
relief from pain and other symptoms associated 
with the disease [4, 5]. According to statistics, 
43% of patients with inoperable lung cancer are 
provided with chemical treatment. It is therefore 
important to ensure them the highest quality of 
life. Overall prognosis is poor because only 10% 
of patients survive one year [6]. Survival period 
after the application of palliative chemotherapy 
has increased slightly from 7.9 to 11.3 months [6].
Cancer-related fatigue syndrome (CRFS) is 
very common in patients with lung cancer. Un-
doubtedly, CRF influences physical, emotional 
and overall patient quality of life [7, 8]. Fatigue is 
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a symptom that is very difficult to define, general-
ly speaking, it can be understood as a subjective 
feeling of weakness, tiredness or exhaustion. It 
is often associated with a noticeable decline in 
activity. Fatigue is one of the frequently reported 
symptoms in patients with lung cancer. Studies 
show that in the case of cancer, fatigue has a sig-
nificant impact on quality of life and patient’s 
independence [8]. The incidence of fatigue among 
cancer patients receiving chemotherapy reach-
es 75–96%. For patients treated with radiation 
therapy — 75–100%, and in patients with ad-
vanced cancer — 33–89% [7, 9].
Statistics show absolutely that the attempts 
of treatment are undertaken only in some patients 
with CRF, and the methods used are often inap-
propriate or suboptimal [10]. Approximately 40% 
of cancer patients with symptoms of fatigue do not 
receive any treatment, and rest is recommended 
to about 40% of them, modification of diet and 
taking vitamins are proposed to 10% of them, and 
pharmaceuticals are recommended to about 6% of 
patients. Treatment of chronic fatigue in cancer pa-
tients should be multi-directed and holistic [11, 12].
The objective of the study was the assessment 
of cancer-related fatigue syndrome in patients 
undergoing palliative chemotherapy because of 
lung cancer.
Material and methods
The study was conducted in the Department 
of Pulmonary Diseases and Treatment of Lung 
Cancer in the Kuyavian-Pomeranian Centre of 
Pulmonology in Bydgoszcz in the period from 
February to June 2016.
The study enrolled 100 patients who under-
went palliative chemotherapy because of lung 
cancer between the 2nd and 4th cycle. 30 people 
refused to participate in the study. 8 patients were 
excluded because of old age, 10 due to obesity 
and 9 patients because of a serious illness of the 
osteoarticular system.
The study was based on socio-demographic 
questionnaire and the cancer-related fatigue 
scale consisting of 22 closed questions, to which 
answers depended on the sensation of fatigue at 
the range from 0 (none) to 10 (very strong). The 
following division of the severity of fatigue was 
adopted: 0–3 mild fatigue, 4–6 moderate and 7–10 
heavy fatigue. All people were informed about the 
goal and voluntary participation before the study. 
In the following part of the study, the level of 
perceived fatigue was analysed. Also estimation 
whether the obtained results were changed by 
the following selected variables: gender, age (age 
groups), education, place of residence, radiation 
therapy, smoking, lowering economic status in 
relation to cancer was made.
The following variables were analysed: gen-
der, place of residence, treatment with radiation 
therapy before palliative chemotherapy, smoking 
and reduced economic status. The Mann-Whitney 
U  test was used to compare two independent 
samples (groups). To evaluate the variables such 
as age group and education, Spearman’s rank cor-
relation test was used. The level of significance 
p ≤ 0.05 was adopted as statistically significant.
Permission for study was obtained from the 
Bioethics Committee at the Collegium Medicum 
UMK in Bydgoszcz.
Results
Socio-demographic and clinical 
characteristics of patients
Men accounted for 68% and patients aged 
51–65 for 60%. Most respondents — 61%, had 
primary/vocational education level. The majority 
(61%) lived in the city. Most respondents — 
57%, were retired/pensioners, 75% of patients 
were married. The majority — 70%, indicated 
that they smoked cigarettes. 86% of patients did 
not undergo radiation therapy before palliative 
chemotherapy. Information about occurrence of 
cancer-related fatigue and counteracting it was 
provided to 83% of patients. 74% of respondents 
had a feeling of reduction of economic status of 
their families because of cancer (Table 1).
Cancer-related fatigue
Most respondents reported that they felt tired 
for several months — 65%, for several weeks — 
16%, for a few days — 11% and 8% of respondents 
did not suffer from fatigue (the time of feeling 
tired — question No. 1).
Of all the statements about behavioural fa-
tigue, the highest average was 5.6 in terms of the 
ability to engage in well-liked activity, occupa-
tion, while the smallest average for disturbance 
to the contact with friends — 5.21 points. The 
average overall score of behavioural/heaviness 
fatigue was 5.34 points (moderate level of fatigue). 
Of all the statements about affective fatigue, the 
most patients indicated the following statement: 
the level of current fatigue as normal-abnormal 
— 5.87, whereas the lowest rated statement was: 
the level of current fatigue as positive–negative — 
6.03 points. Average affective fatigue amounted 
to — 5.89 points (moderate level of fatigue).
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Table 1. Socio-demographic and clinical data
Variable n = %
Sex Woman 32
Man 68
Age 40–50 years 8
51–65 years 60






Place of residence Village 39
City 61









Does not work 7





 Radiotherapy Yes 14
No 86
Provide information about fatigue Yes 83
No 17
Reduction of economic status Yes 74
No 26
Of all the statements on sensory fatigue, 
the top rated question was as follows: to what 
extent do you feel strong — 5.35 points, while 
the lowest rated question read: to what extent 
do you feel rested — 5.6 points. The average 
sensory fatigue was — 5.44 points (moderate 
level of fatigue). Of all the statements on cogni-
tive/mood fatigue, the patients rated as highest 
the following question: how do you assess your 
ability to memorise — 2.98 points, and as the 
lowest they rated the following question: to 
what extent do you feel joyful — average value 
— 5.6 points. The average severity of cognitive/
mood fatigue was — 4.29 points (lower level of 
moderate fatigue). Average severity of general 
fatigue amounted to 5.2 points (moderate level 
of fatigue). The most severe was affective fatigue 
at average value — 5.89 points. The least severe 
was cognitive/mood fatigue, at average value 
— 4.29 points (Table 2). 
Most patients — 44%, felt moderate be-
havioural fatigue and 42% of patients experienced 
serious affective fatigue. Sensory fatigue and cog-
nitive/mood fatigue were perceived as moderate 
by 44% and 55% of patients, respectively. Mod-
erate general fatigue was felt by 51% of people. 
6% of patients did not suffer from fatigue at all 
(Table 3).
Cancer-related fatigue according to the se-
lected variables: sex, age, education, place of 
residence, economic status, smoking and radio-
therapy
There was no difference in the perception of 
different types of fatigue between men and wom-
en (p > 0.05). Slightly more women felt fatigue 
especially in the field of affective fatigue, average 
value — 6.15 points. Patients had a similar level 
of experienced fatigue (p > 0.05) regardless of 
age. Patients aged 40–50 had a highest average 
score of feeling of fatigue, average value — 5.91 
points, the lowest one was observed in patients 
aged 51–60, average value — 4.99 points.
Education had an influence on the perception 
of each type of fatigue (p < 0.05). Higher general 
fatigue was felt by respondents with primary/voca-
tional education, average value was — 5.75 points, 
the lowest general fatigue by patients with higher 
education, average value — 4.08 points. Residents 
of cities or villages had similar levels of perceived 
fatigue (p > 0.05). Higher fatigue was felt by vil-
lagers — average 5.43. Smokers and non-smokers 
suffered from fatigue at similar level (p > 0.05). 
Slightly higher fatigue was felt by non-smokers 
— average value 5.31. Reduction of the economic 
status of the family because of cancer affected the 
level of perceived affective, sensory, cognitive/
mood and general fatigue (p < 0.05).
Higher general fatigue was experienced by 
respondents with lower economic status — av-
erage 5.48 points. Radiotherapy had an effect 
on cognitive/mood fatigue (p = 0.037). Higher 
general fatigue was felt by patients after radio-
therapy — average value 5.85 points (p = 0.453) 
(Table 4).
Correlations between various types of fatigue
There were statistically significant strong 
correlations between various types of fatigue and 
general fatigue. With the growth of one type of 
fatigue, the severity of other types of fatigue also 
grew (Table 5).
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Table 2. The mean scores of statements about fatigue 
Type of  
fatigue
No. Statement/question Mean/SD General 
mean/SD 
Behavioral 2 The degree of unpleasantness of fatigue 5.38/2.84 5.34/2.46
3 Disturbing activities by fatigue 5.33/2.92
4 The degree of disruption of contacts with friends 5.21/2.87
5 The degree of annoyance in sexual life 5.13/2.81
6 The ability to engage in well-liked activity, classes 5.6/2.64
7 The degree of intensity and severity of experienced fatigue 5.39/2.74
Affective 8 The degree of determining of the current fatigue as pleasant or 
unpleasant
5.97/2.65 5.89/2.55
9 The degree of determining of the current fatigue as bearable or 
unbearable
5.62/2.79
10 The extent to which you would describe the currently existing 
fatigue as protective or devastating
5.96/2.68
11 The degree of determining the current level of fatigue as positive 
or negative
6.03/2.8
12 The degree of determining the current level of fatigue as normal 
or abnormal
5.87/2.69
Sensory 13 To what extent do you feel strong? 5.35/2.57 5.44/2.45
14 To what extent do you feel awake? 5.4/2.6
15 To what extent do you feel excited? 5.31/2.63
16 To what extent do you feel rested? 5.6/2.63
17 To what extent do you feel energetic? 5.56/2.63
Cognitive/ 
/mood
18 To what extent do you feel calm or patient? 5.39/2.71 4.29/1.90
19 To what extent do you feel relaxed? 5.6/2.61
20 To what extent do you feel joyful? 5.6/2.65
21 How do you assess your ability to concentrate? 3.5/2.25
22 How do you assess your ability to remember? 2.98/2.33
23 How do you assess your ability to think? 2.64/2.23
Table 3. The number of patients in the various grades of fatigue 
Type of fatigue Behavioral Affective Sensory Cognitive/
/mood
General
Degree n = %
Lack of fatigue 6 6 6 6 6
Mild 15 12 15 24 15
Moderate 44 40 44 55 51
Serious 35 42 35 15 28
Total 100 100 100 100 100
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Table 4. The mean scores of fatigue in groups of variables




Sex Woman 5.82/1.85 6.15/2.1 5.74/1.95 4.4/1.65 5.49/1.67
Man 5.12/2.68 5.77/2.74 5.3/2.66 4.23/2.02 5.06/2.37
p 0.335 0.814 0.297 0.259 0.601
Age 40–50 years 5.88/1.93 6.8/2.5 6.4/2.31 4.81/1.55 5.91/1.93
51–65 years 5.13/2.46 5.73/2.6 5.05/2.43 4.19/2.01 4.99/2.18
More than 65 lat 5.59/2.59 5.97/2.49 5.94/2.45 4.33/1.79 5.41/2.23
p 0.708 0.91 0.321 0.499 0.335
Education Primary/vocational 5.99/2.23 6.36/2.2 5.95/2.2 4.81/1.72 5.75/1.89
Secondary 4.41/2.24 5.23/2.7 4.66/2.46 3.51/1.75 4.41/2.13
Higher 3.93/3.6 4.8/3.9 4.57/3.57 3.21/2.66 4.08/3.35
p 0.011 0.03 0.021 0.001 0.007
Place of residence Village 5.79/2.03 6.16/2.33 5.57/2.32 4.35/1.77 5.43/1.92
City 5.05/2.67 5.72/2.69 5.36/2.55 4.24/1.99 5.05/2.33
p 0.287 0.54 0.693 0.547 0.802
Smoking Yes 5.23/2.54 5.88/2.58 5.27/2.47 4.38/1.98 5.15/2.23
No 5.61/2.26 5.91/2.51 5.85/2.41 4.07/1.73 5.31/2.08
p 0.755 0.721 0.958 0.527 0.821
Reduction of econo-
mic status
Yes 5.59/2.44 6.21/2.5 5.81/2.49 4.49/2.05 5.48/2.21
No 4.63/2.41 4.99/2.51 4.41/2.05 3.71/1.28 4.41/1.88
p 0.083 0.036 0.01 0.046 0.007
 Radiotherapy Yes 5.81/1.34 6.74/1.75 6.06/1.74 4.98/1.49 5.85/1.38
No 5.26/2.59 5.75/2.64 5.34/2.54 4.17/1.95 5.1/2.27
p 0.766 0.185 0.49 0.037 0.453
Table 5. The relationships between the types of fatigue
Behavioural Affective Sensory Cognitive/mood General fatigue
Behavioral 0.850 0.832 0.744 0.940
Affective 0.850 0.795 0.717 0.921
Sensory 0.832 0.795 0.751 0.919
Cognitive/mood 0.744 0.717 0.751 0.844
General fatigue 0.940 0.921 0.919 0.844
Multivariate analysis of influence of selected 
variables on the general cancer fatigue
Using a multivariate analysis (logistic re-
gression), the attempt to examine the impact 
of the selected variables such as gender, age, 
professional activity, radiation therapy, smoking 
and reducing the economic status of the family 
on severity of the fatigue has been made. Only 
the reduction of the economic status affected 
the severity of general cancer-related fatigue 
(p < 0.005) (Table 6).
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Table 6. Parameters of estimated model of general fatigue
The final loss: 44.153850950 Chi2(6) = 14.484 p = 0.0247
Constant.B0 Sex Age Professional 
activity
Smoking Reduction of economic 
status due to illness
Radiotherapy
Rating 7.995 –1.332 0.357 –0.290 0.057 –1.639 –1.200
Standard error 3.046 0.729 0.519 0.349 0.603 0.586 1.124
Student t (91) 2.624 –1.827 0.687 –0.831 0.095 –2.798 –1.068
 p 0.010 0.071 0.493 0.408 0.924 0.006 0.288
 –95%CL 1.946 –2.780 –0.673 –0.984 –1.14 –2.802 –3.433
 +95%CL 14.044 0.116 1.387 0.403 1.255 –0.476 1.032
Wald chi2 6.888 3.339 0.473 0.691 0.009 7.831 1.140
p 0.009 0.068 0.492 0.406 0.924 0.005 0.286
Odds ratio of unit change 2965.897 0.264 1.429 0.748 1.059 0.194 0.301
 –95%CL 6.997 0.062 0.510 0.374 0.32 0.061 0.032
 +95%CL 1257099 1.123 4.002 1.496 3.508 0.621 2.808
Odds ratio of the range 0.264 2.041 0.419 1.059 0.194 0.301
 –95%CL 0.062 0.260 0.052 0.32 0.061 0.032
 +95%CL 1.123 16.014 3.351 3.508 0.621 2.808
    
Discussion
The interest in fatigue felt by oncological 
patients have increased recently. Taking into 
account the latest research, it is most common 
factor deteriorating the quality of life reported by 
patients [13]. Despite the already known proce-
dures, both pharmacological and non-pharmaco-
logical, the problem is often underestimated by 
the medical community [13].
In the case of cancer patients, the severity 
of fatigue may result from many factors. Hence, 
the attempt has been made to investigate wheth-
er the variables such as gender, age, education, 
place of residence, professional activity, smok-
ing, lowering the economic status of the family 
have an impact on the severity of weariness. The 
assessment was difficult due to the subjective 
nature of fatigue. The number of scientific reports 
examining this issue in patients during palliative 
chemotherapy is very small.
The vast majority of the respondents were 
men as confirmed by epidemiological data. More 
than half of the respondents were aged 51–65, 
lived in a city and had vocational/primary educa-
tion. Most women and men declared that they had 
information about cancer fatigue and how to deal 
with it. However, other studies deny this. A recent 
study on people undergoing chemotherapy have 
shown that nearly half of cancer patients have 
little awareness about available possibilities of as-
sessing and combating fatigue. Knowledge of the 
treatment of cancer-related fatigue is still not wide-
spread enough among doctors and nurses [14]. 
Our analysis shows that despite the diagnosed 
cancer most patients had not abandoned smoking 
habit and surprisingly smokers suffered from less 
severe fatigue.
In our study, patients have already felt 
fatigue usually for several months. Only few 
patients did not experience fatigue at all. The 
Department of Psychiatry and Psychotherapy at 
the University of Cologne reported that half of 
cancer patients feel fatigue during diagnostic 
examination already. In patients undergoing 
chemotherapy accumulation of symptoms is 
usually seen after intravenous administration of 
drugs. It reaches maximum intensity after 48–72 
hours from the implementation of chemotherapy 
and then, in about three weeks fatigue symptoms 
gradually decrease. A way of feeling the symp-
toms of chronic fatigue syndrome by patients 
may be related to the type of chemotherapeutic 
agents used [15].
The following factors did not have a signifi-
cant impact on the severity of fatigue: sex, marital 
status, vocational activity and place of residence. 
Slightly stronger fatigue was felt by the group 
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aged between 40 and 50, the lowest between 
51 and 60-year-old. According to a  study per-
formed in patients after palliative chemotherapy 
being cared in hospices and also among elder 
patients, these communities include the largest 
group of people with low intensity of fatigue [16]. 
It appears that older people report lower levels of 
fatigue than the younger one. The fact of lower 
intensity of sensation of fatigue in the elderly 
could be explained by their smaller needs and 
expectations in relation to life. It is easier for 
them to come to terms with the limitations posed 
by cancer.
Taking into account the education level, 
those with higher education felt less fatigue. 
People with vocational education in everyday life 
often perform harder physical work than people 
with higher education. Other studies conducted 
among people undergoing chemotherapy have 
demonstrated that patients with higher education 
have higher levels of fatigue than housewives liv-
ing with their families [15]. In our study, previous 
treatment with radiotherapy prior to treatment 
with palliative chemotherapy had an effect on 
the severity of fatigue. Research conducted in 
the Department of Radiotherapy of the European 
Institute of Radiology in patients undergoing ra-
diotherapy confirms its effect on fatigue, which 
is observed in most patients [17].
In addition, an attempt was made to examine 
the severity of individual statements about cancer 
fatigue, taking into account the selected variables. 
Behavioural, sensory, cognitive/mood and general 
fatigue appeared mostly in moderate intensity. 
Only affective fatigue occurred in severe intensity 
more often. Other results taking into account the 
level of fatigue and associated psychosocial fac-
tors in the palliative treatment measured at the 
time, have shown that not every patient suffers 
from severe fatigue. Almost half of patients do not 
feel severe fatigue. What is interesting, the level 
of fatigue does not change during the course of 
treatment in every third patient [14]. The studies 
into the impact of fatigue on quality of life in 
patients undergoing chemotherapy because of 
lung cancer have shown that most patients have 
moderate level of fatigue. Every fifth patient does 
not report fatigue at all during treatment, and 
the average intensity of fatigue is at a low level 
[18, 19].
Additionally, a multivariate analysis was 
made taking into account all previously pre-de-
fined variables, and only reduction of economic 
status in the family because of cancer had a sig-
nificant effect on the intensity of fatigue. 
Basing on our analysis, the fatigue is a very 
troublesome problem for most patients with lung 
cancer treated with palliative chemotherapy. This 
problem affects almost all patients. Therefore, it 
is important to conduct further studies assessing 
the intensity of cancer- related fatigue during 
cancer treatment. Awareness about the occur-
rence of cancer-related fatigue and also about 
how pharmacological and non-pharmacological 
methods for dealing with this problem can help 
to improve the quality of life.
Conclusions
1.  In patients receiving chemotherapy because 
of lung cancer, fatigue associated with cancer 
occurs in moderate intensity and lasts for 
several months in half of them.
2.  Behavioural, sensory, cognitive/mood and 
general fatigue have moderate intensity, 
while affective fatigue has severe intensity.
3.  Radiation therapy affects the severity of cog-
nitive/mood fatigue, lower economic status 
has impact on behavioural fatigue, and edu-
cation affects general fatigue.
4.  In the multivariate analysis, only the reduc-
tion of the economic status has a significant 
effect on the severity of general cancer-relat-
ed fatigue.
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